Germany· DE-A57-0913393a20da1ecf
Mg 5-Longoral
A medicinal product containing magnesiumbis(hydrogen-dl-aspartate) tetrahydrate, registered in Germany by Drossapharm Arzneimittel Handelsgesellschaft Mbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Magnesiumbis(Hydrogen-Dl-Aspartate) Tetrahydrate
- Manufacturer
- Drossapharm Arzneimittel Handelsgesellschaft Mbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 23, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Magnesiumbis(hydrogen-dl-aspartate) tetrahydrate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAsparDose 243mg (magnesium 10mmol) oral powder sachetsTriOn Pharma Ltd
- SwitzerlandMg 5-Granoral 12mmol arôme pêche-abricot, granulé buvableOM Pharma Suisse SA
- PolandAsmagPrzedsiębiorstwo Farmaceutyczne Farmapol Sp. z o.o.
- BelgiumMagnence 243 mgKora Corporation t/a Kora Healthcare
- NetherlandsMagnence 243 mg poeder voor drankKora Corporation Ltd t/a Kora Healthcare
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Emgecard, Magnesiocard
- Bulgaria · Магнерич
- Cyprus · Trofocard
- United Kingdom (Northern Ireland) · Anosumag
- Greece · Magnesil, Overmag
- Poland · Asmag, Asmag Forte
- Portugal · Magnesiocard, Magnesiocard Sem Açúcar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdd56687-a9e7-4a37-8370-87bcd1386a5b GET /v1/drugs/cdd56687-a9e7-4a37-8370-87bcd1386a5b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Magnesiumbis(Hydrogen-Dl-Aspartate) Tetrahydrate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about magnesiumbis(hydrogen-dl-aspartate) tetrahydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.